Literature DB >> 5165303

When is multiple sclerosis acquired?

M Alter, M Okihiro.   

Abstract

Entities:  

Mesh:

Year:  1971        PMID: 5165303     DOI: 10.1212/wnl.21.10.1030

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  12 in total

1.  Comparative epidemiological studies of multiple sclerosis in South Africa and Japan.

Authors:  A V Bird; E Satoyoshi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-09       Impact factor: 10.154

Review 2.  Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease.

Authors:  Robert S Fujinami; Matthias G von Herrath; Urs Christen; J Lindsay Whitton
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

3.  Multicenter case-control study of multiple sclerosis and risk factors. Design of study. The Coordinating Center and the Neurological Centers of the Cooperative Group.

Authors: 
Journal:  Ital J Neurol Sci       Date:  1986-04

Review 4.  What if multiple sclerosis isn't an immunological or a viral disease? The case for a circulating toxin.

Authors:  F Wolfgram
Journal:  Neurochem Res       Date:  1979-02       Impact factor: 3.996

5.  Sphingolipids and their precursors in human brain (normal and MS).

Authors:  B Gerstl; M G Tavaststjerna; L F Eng; J K Smith
Journal:  Z Neurol       Date:  1972

6.  Epidemiology of multiple sclerosis.

Authors: 
Journal:  Br Med J       Date:  1979-12-01

Review 7.  A review of the etiology of multiple sclerosis.

Authors:  V Vella
Journal:  Ital J Neurol Sci       Date:  1984-12

8.  Racial predilection in multiple sclerosis.

Authors:  M Alter; M Harshe
Journal:  J Neurol       Date:  1975-08-04       Impact factor: 4.849

9.  Subclinical multiple sclerosis.

Authors:  M Morariu; W F Klutzow
Journal:  J Neurol       Date:  1976-07-15       Impact factor: 4.849

Review 10.  Epidemiologic evidence for multiple sclerosis as an infection.

Authors:  J F Kurtzke
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.